J&J's Janssen hit with $70 million verdict in Risperdal trial

July 2016

Reuters reports: “A U.S. jury on Friday awarded $70 million to the family of a boy who developed breasts after taking Johnson & Johnson unit Janssen Pharmaceuticals' antipsychotic drug Risperdal.”